GURUFOCUS.COM » STOCK LIST » Industrials » Construction » ChromoGenics AB (OSTO:CHRO) » Definitions » Capital Expenditure

ChromoGenics AB (OSTO:CHRO) Capital Expenditure : kr-0.47 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ChromoGenics AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

ChromoGenics AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-0.14 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.47 Mil.


ChromoGenics AB Capital Expenditure Historical Data

The historical data trend for ChromoGenics AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromoGenics AB Capital Expenditure Chart

ChromoGenics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only -6.41 -68.96 -20.69 -15.99 -4.93

ChromoGenics AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.23 -0.18 -0.19 -0.14 -0.14

ChromoGenics AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChromoGenics AB (OSTO:CHRO) Business Description

Traded in Other Exchanges
Address
Ullforsgatan 15, Uppsala, SWE, 752 28
ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.

ChromoGenics AB (OSTO:CHRO) Headlines